These are past and ongoing clinical trials for the last 5 years that patients have been offered at the Institute...
HYMN: A Randomised controlled phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guérin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guérin therapy. Start date: 1 Mar 2010 Finish date: 1 Mar 2013 Chief Investigator - Prof John Kelly, UCLH [Complete article]
BOLERO - Bladder cancer: Open versus Lapraroscopic or RObotic cystectomy. A study to determine the feasibility of randomisation to open versus minimal access cystectomy in patients with muscle invasive bladder cancer. Start date: Finish date: Chief Investigator - Prof John Kelly, UCLH [Complete article]
HIFU Lesion Control in Patients With Non-metastatic Progressive Prostate Cancer Start date: 1 Jul 2009 Finish date: Chief Investigator - Mark Emberton, UCLH [Complete article]
PHASE II Vascular-Targeted Photodynamic Therapy Using WST 11 in Patients With Localized Prostate Cancer Start date: 1 Sep 2008 Finish date: 1 Dec 2009 Chief Investigator - Mark Emberton, UCLH [Complete article]